“This collaboration has allowed us to study the effectiveness of MeRT™,” said U.S. Navy Capt. Scott Cota,the principal investigator of the study assigned to USSOCOM.
“This technology has proven safe and highly effective for the treatment of medication resistant depression, and our studies aim to validate MeRT™ effectiveness for treating symptoms of PTS.”
